Selskabets formål er at udvikle repositionerede lægemidler samt dermed beslægtede aktiviteter
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 0 | -6.3 mio. | 12.1 mio. | 4.8 mio. | - | |
CVR: 36494433
Compared to 131 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Companies in the same industry and area
CVR 30082346
CVR 37509736
CVR 39161672
CVR 41489189
CVR 44807866
Troels Peter Troelsen joined the board
Henrik Bulskov joined the board
Troels Peter Troelsen left the board
Henrik Bulskov left the board
DMZ HOLDING ApS registered with 15% ownership
Preben Møllegaard Grundtvig left the board
Sigbjørn Georg Nielsen Kjærgård left the board
companydata.dk